Standigm secures SI investment for expanding its AI-drug development capacity

(Standigm Inc.) " This partnership will help us to commercialize our AI-driven drug candidates and enhance our ability and expertise in drug development, " said Jinhan Kim, co-founder and CEO of Standigm.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news